Targeting DLL3: A New Weapon in Lung Neuroendocrine Tumors?

Mariona Riudavets, David Planchard

Résultats de recherche: Contribution à un journal › Editorial

langue originale	Anglais
Numéro d'article	100796
journal	JTO Clinical and Research Reports
Volume	6
Numéro de publication	5
Les DOIs	https://doi.org/10.1016/j.jtocrr.2025.100796
état	Publié - 1 mai 2025

Accès au document

@article{f7090a249e7247af9e6dfde914305db5,

title = "Targeting DLL3: A New Weapon in Lung Neuroendocrine Tumors?",

author = "Mariona Riudavets and David Planchard",

year = "2025",

month = may,

day = "1",

doi = "10.1016/j.jtocrr.2025.100796",

language = "English",

volume = "6",

journal = "JTO Clinical and Research Reports",

issn = "2666-3643",

number = "5",

}

TY - JOUR

T1 - Targeting DLL3

T2 - A New Weapon in Lung Neuroendocrine Tumors?

AU - Riudavets, Mariona

AU - Planchard, David

PY - 2025/5/1

Y1 - 2025/5/1

UR - http://www.scopus.com/inward/record.url?scp=105000723784&partnerID=8YFLogxK

U2 - 10.1016/j.jtocrr.2025.100796

DO - 10.1016/j.jtocrr.2025.100796

M3 - Editorial

AN - SCOPUS:105000723784

SN - 2666-3643

VL - 6

JO - JTO Clinical and Research Reports

JF - JTO Clinical and Research Reports

IS - 5

M1 - 100796

ER -